Literature DB >> 26464646

Reduced expression of E-cadherin and p120-catenin and elevated expression of PLC-γ1 and PIKE are associated with aggressiveness of oral squamous cell carcinoma.

Yi Jiang1, Liyan Liao1, Chandrama Shrestha2, Shangli Ji2, Ying Chen3, Jian Peng2, Larry Wang4, Eryuan Liao2, Zhongjian Xie2.   

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most lethal malignant tumors. The cadherin/catenin cell-cell adhesion complex plays a major role in cancer development and progression. p120-catenin (p120) is a cytoplasmic molecule closely associated with E-cadherin which activates phospholipase C-γ1 (PLC-γ1). Our previous studies indicate that activation of PLC-γ1 plays a critical role in epidermal growth factor (EGF)-induced migration and proliferation of squamous cell carcinoma (SCC) cells and phosphatidylinositol 3-kinase enhancer (PIKE) is highly expressed in SCC cells and mediates EGFR-dependent SCC cell proliferation. Our current study was to determine whether the expression of E-cadherin, p120, PLC-γ1, and PIKE, is associated with OSCC. To address this issue, we assessed levels and localization of E-cadherin, p120, PLC-γ1, and PIKE in specimen of 92 patients with OSCC by immunohistochemistry. The results showed that the expression of E-cadherin, and p120 negatively correlated with the tumor differentiation and the expression of PLC-γ1 and PIKE positively correlated with the tumor differentiation. The expression of PLC-γ1 and PIKE in OSCC stage T3 + T4 or in OSCC with lymph node metastasis was significantly higher than that in OSCC stage T1 + T2 or in OSCC without lymph node metastasis. The expression of p120 positively correlated with levels of E-cadherin but negatively correlated with levels of PLC-γ1 and PIKE in OSCC. These data indicate that increased expression of PLC-γ1 and PIKE and decreased expression of E-cadherin and p120 are associated with the aggressiveness of OSCC.

Entities:  

Keywords:  E-cadherin; OSCC; PIKE; PLC-γ1; p120

Mesh:

Substances:

Year:  2015        PMID: 26464646      PMCID: PMC4583878     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  42 in total

1.  Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.

Authors:  Chi-Chen Fan; Tao-Yeuan Wang; Yen-An Cheng; Shih Sheng Jiang; Chien-Wen Cheng; Alan Yueh-Luen Lee; Ting-Yu Kao
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

2.  PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells.

Authors:  Z Xie; Y Jiang; E-Y Liao; Y Chen; S D Pennypacker; J Peng; S M Chang
Journal:  Oncogene       Date:  2012-02-20       Impact factor: 9.867

3.  Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.

Authors:  Sabrina Daniela da Silva; Grégoire B Morand; Faisal A Alobaid; Michael P Hier; Alex M Mlynarek; Moulay A Alaoui-Jamali; Luiz Paulo Kowalski
Journal:  Clin Exp Metastasis       Date:  2014-11-30       Impact factor: 5.150

4.  Changed expression of E-cadherin and galectin-9 in oral squamous cell carcinomas but lack of potential as prognostic markers.

Authors:  Siew Wui Chan; Thomas George Kallarakkal; Mannil Thomas Abraham
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Expression of E-cadherin and matrix metalloproteinase-9 in oral squamous cell carcinoma and histologically negative surgical margins and association with clinicopathological parameters.

Authors:  Nooshin Mohtasham; Kazem Anvari; Bahram Memar; Nasrollah Saghravanian; Narges Ghazi; Ali Bagherpour; Mahshid Ramtin
Journal:  Rom J Morphol Embryol       Date:  2014       Impact factor: 1.033

6.  Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.

Authors:  Khaled Waleed Zaid
Journal:  Asian Pac J Cancer Prev       Date:  2014

7.  The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma.

Authors:  Mihai Cătălin Afrem; Claudiu Mărgăritescu; Monica Mihaela Crăiţoiu; Mirela Ciucă; Călin Gabriel Şarlă; Ovidiu Simion Cotoi
Journal:  Rom J Morphol Embryol       Date:  2014       Impact factor: 1.033

8.  E-cadherin expression and prognosis of oral cancer: a meta-analysis.

Authors:  Sheng-Lei Luo; Yong-Gang Xie; Zhen Li; Jia-Hai Ma; Xin Xu
Journal:  Tumour Biol       Date:  2014-02-27

9.  The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.

Authors:  G Pannone; A Santoro; A Feola; P Bufo; P Papagerakis; L Lo Muzio; S Staibano; F Ionna; F Longo; R Franco; G Aquino; M Contaldo; S De Maria; R Serpico; A De Rosa; C Rubini; S Papagerakis; A Giovane; V Tombolini; A Giordano; M Caraglia; M Di Domenico
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

10.  Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases.

Authors:  Partheeban Balasundaram; Manoj Kumar Singh; Amit Kumar Dinda; Alok Thakar; Rajni Yadav
Journal:  Diagn Pathol       Date:  2014-07-21       Impact factor: 2.644

View more
  9 in total

1.  p120-catenin suppresses proliferation and tumor growth of oral squamous cell carcinoma via inhibiting nuclear phospholipase C-γ1 signaling.

Authors:  Lusha Li; Shangli Ji; Chandrama Shrestha; Yi Jiang; Liyan Liao; Feng Xu; Zhenming Liu; Daniel D Bikle; Zhongjian Xie
Journal:  J Cell Physiol       Date:  2020-04-30       Impact factor: 6.384

2.  Association between periostin and epithelial-mesenchymal transition in esophageal squamous cell carcinoma and its clinical significance.

Authors:  Ya-Jing Lv; Wei Wang; Chu-Shu Ji; Ming-Ran Xie; Bing Hu
Journal:  Oncol Lett       Date:  2017-05-05       Impact factor: 2.967

3.  p120-catenin is required for regulating epidermal proliferation, differentiation, and barrier function.

Authors:  Zhongjian Xie; Yuanyuan Tang; Mao-Qiang Man; Chandrama Shrestha; Daniel D Bikle
Journal:  J Cell Physiol       Date:  2018-06-19       Impact factor: 6.384

4.  Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma.

Authors:  Haichao Liu; Cheng Wang; Nan Xie; Zehang Zhuang; Xiqiang Liu; Jinsong Hou; Hongzhang Huang
Journal:  Int J Mol Med       Date:  2017-11-09       Impact factor: 4.101

5.  Overexpression of PTPRZ1 Regulates p120/β-Catenin Phosphorylation to Promote Carcinogenesis of Oral Submucous Fibrosis.

Authors:  Liwei Ma; Ting Shen; Hui Peng; Jianjun Wu; Wenjin Wang; Xing Gao
Journal:  J Oncol       Date:  2022-02-23       Impact factor: 4.375

6.  Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells.

Authors:  Stephanie A Sheehan; Edward P Retzbach; Yongquan Shen; Harini Krishnan; Gary S Goldberg
Journal:  Cell Commun Signal       Date:  2022-02-17       Impact factor: 5.712

7.  Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva.

Authors:  S López-Verdín; J-J Soto-Avila; A-L Zamora-Perez; B-P Lazalde-Ramos; M-L Martínez-Fierro; R González-González; N Molina-Frechero; M-A Isiordia-Espinoza; R Bologna-Molina
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-11-01

8.  PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer.

Authors:  Junyong Weng; Jingbo Xiao; Yushuai Mi; Xu Fang; Yahuang Sun; Shanbao Li; Zhiwei Qin; Xu Li; Tingting Liu; Senlin Zhao; Lisheng Zhou; Yugang Wen
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

9.  WISP-1 Promotes Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells Via the miR-153-3p/Snail Axis.

Authors:  An-Chen Chang; Ming-Yu Lien; Ming-Hsui Tsai; Chun-Hung Hua; Chih-Hsin Tang
Journal:  Cancers (Basel)       Date:  2019-11-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.